Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people w ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

More debate about whether the lowest-risk prostate cancers should even be called "cancer." (Harvard Health Publishing) Four ...

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...

Although Pfizer is not among the drugmakers suing the government to block negotiations, it has said the program will hinder drug R&D and innovation.

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

Novo Nordisk's Ozempic and Wegovy, among 15 drugs including Pfizer's Ibrance, will face Medicare price negotiations in 2027, ...

The Biden administration released another list of prescriptions drugs that would be subject to price controls. The price ...

The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be ...

Announcement of the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final ...

Pfizer raised prices of the most drugs on the latest list, including Paxlovid, Nurtec, Adcetris, Ibrance, and Xeljanz between 3% and 5%. Bristol Myers raised the price of its expensive cancer cell ...

Novartis’ challenge to Pfizer’s blockbuster breast cancer drug, Ibrance, is building momentum, after the US regulator granted it a fast review. The US Food and Drug Administration granted the ...